Analyst Price Targets — SCI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 1, 2026 1:06 pm | — | UBS | $93.00 | $79.40 | TheFly | Service Corp. price target lowered to $93 from $95 at UBS |
| October 30, 2025 7:21 pm | — | Truist Financial | $100.00 | $83.77 | TheFly | Service Corp. price target raised to $100 from $92 at Truist |
| October 22, 2025 12:25 pm | — | Oppenheimer | $94.00 | $82.80 | TheFly | Service Corp. price target raised to $94 from $91 at Oppenheimer |
| October 13, 2025 12:01 pm | — | UBS | $95.00 | $82.53 | TheFly | Service Corp. price target raised to $95 from $88 at UBS |
| August 21, 2025 2:57 pm | Scott Schneeberger | Oppenheimer | $91.00 | $81.23 | TheFly | Service Corp. price target raised to $91 from $86 at Oppenheimer |
| August 4, 2025 12:16 pm | — | Raymond James | $90.00 | $78.45 | TheFly | Service Corp. price target raised to $90 from $85 at Raymond James |
| June 21, 2024 8:19 am | Tobey Sommer | Truist Financial | $84.00 | $72.02 | TheFly | Service Corp. price target raised to $84 from $80 at Truist |
| May 22, 2024 7:43 am | Scott Schneeberger | Oppenheimer | $79.00 | $70.10 | TheFly | Service Corp. price target raised to $79 from $76 at Oppenheimer |
| May 17, 2024 5:57 am | AJ Rice | UBS | $85.00 | $70.78 | StreetInsider | Service Corp. Intl. (SCI) PT Raised to $85 at UBS |
Latest News for SCI
HOUSTON, July 16, 2026 /PRNewswire/ -- Service Corporation International (NYSE: SCI) announced it expects to issue a press release with financial results for the second quarter 2026 on Wednesday, July 29, 2026. A conference call will be hosted by SCI Management on Thursday, July 30, 2026.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI to launch FDA Registration-Enabling Phase 3 Confirmatory Study to bring Multikine to Market for newly diagnosed head and neck cancer.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #BIO2026--CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI announces closing of offering.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI advances Multikine immunotherapy for Head and Neck Cancer through dual U.S. registration study and Saudi market entry strategy.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.